Regulation
FDA grants breakthrough device status to Teleflex’s coronary scaffold
Teleflex received FDA breakthrough device designation for its Freesolve RMS coronary scaffold, intended for percutaneous coronary intervention (PCI). Breakthrough status expedites FDA review and signals potential clinical significance for the device.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network